Chemical Biology & Drug Design

Papers
(The H4-Index of Chemical Biology & Drug Design is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Antioxidant activities and mechanisms of polysaccharides98
Extraction, separation, modification, structural characterization, and antioxidant activity of plant polysaccharides90
Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review85
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy81
Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy64
1,3,4‐oxadiazole and its derivatives: A review on recent progress in anticancer activities63
Chromones: Privileged scaffold in anticancer drug discovery44
Preparation, structure, and properties of tea polysaccharide34
Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain33
Repurposing potential of FDA‐approved and investigational drugs for COVID‐19 targeting SARS‐CoV‐2 spike and main protease and validation by machine learning algorithm32
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic32
Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—An updated review31
Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK‐3β/β‐catenin signaling pathway28
Therapeutic potential and pharmacological activities of β‐eudesmol28
Application of molecular dynamics simulation in biomedicine26
Evolution of peptide nucleic acid with modifications of its backbone and application in biotechnology25
Antimicrobial and antiproliferative activities of novel synthesized 6‐(quinolin‐2‐ylthio) pyridine derivatives with molecular docking study as multi‐targeted JAK2/STAT3 inhibitors25
Recent advances in Bcr‐Abl tyrosine kinase inhibitors for overriding T315I mutation25
Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors24
Extraction, derivatization, and antioxidant activity of Morinda citrifolia polysaccharide23
Specific delivering of RNAi using Spike's aptamer‐functionalized lipid nanoparticles for targeting SARS‐CoV‐2: A strong anti‐Covid drug in a clinical case study23
Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review23
An overview on synthetic and pharmaceutical prospective of pyrido[2,3‐d]pyrimidines scaffold22
0.03057599067688